Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Net Income towards Common Stockholders (2016 - 2025)

Dexcom (DXCM) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with $267.3 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 76.2% to $267.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $836.3 million through Dec 2025, up 45.14% year-over-year, with the annual reading at $836.3 million for FY2025, 45.14% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $267.3 million at Dexcom, down from $283.8 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $283.8 million in Q3 2025, with the low at -$5.3 million in Q4 2021.
  • Average Net Income towards Common Stockholders over 5 years is $125.6 million, with a median of $110.6 million recorded in 2023.
  • The sharpest move saw Net Income towards Common Stockholders crashed 101.29% in 2021, then surged 1832.08% in 2022.
  • Over 5 years, Net Income towards Common Stockholders stood at -$5.3 million in 2021, then soared by 1832.08% to $91.8 million in 2022, then skyrocketed by 179.19% to $256.3 million in 2023, then plummeted by 40.81% to $151.7 million in 2024, then soared by 76.2% to $267.3 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $267.3 million, $283.8 million, and $179.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.